GHIT Fund 與泰國科學、研究與創新局（TSRI）簽署備忘錄以加強合作夥伴關係

常見問題

Q: What is the main purpose of the partnership between GHIT Fund and TSRI?

A: The main purpose is to strengthen their partnership to create opportunities for joint funding (Co-Funding) in research and development for infectious diseases such as malaria, tuberculosis, neglected tropical diseases (NTDs), and potential pandemic pathogens.

Q: What are the key areas of collaboration outlined in the MOU?

A: The key areas include: 1) Creating opportunities for joint funding for R&D projects in Thailand targeting infectious diseases. 2) Promoting R&D in infectious disease areas like NTDs by revitalizing research and innovation in Thailand and Japan. 3) Sharing expertise and knowledge through workshops and exchanges regarding infectious diseases.

Q: What is GHIT Fund's role in global health?

A: GHIT Fund invests in (grants for) the R&D of therapeutics, vaccines, and diagnostics for infectious diseases that threaten the health of low- and middle-income countries. It acts as a bridge connecting researchers and institutions to drive product development.

Q: What is TSRI's role in Thailand?

A: TSRI is a government agency responsible for formulating national strategies and policies for science, research, and innovation (SRI) in Thailand. It promotes research and innovation by allocating the SRI budget to various institutions.

Q: How will this partnership benefit Thailand?

A: The partnership will expand opportunities for additional financial support to Thai research institutions and researchers working on infectious diseases. It will also help revitalize research and technological innovation in Thailand and foster knowledge sharing.